SCHACHLE JOSEPH K
SEC CIK 1145914 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | COO | 291.4K | $4,100 | $57.7K | 6 | 2024-03-21 | 2026-07-23 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 16:07 | 2026-07-23 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | S - Sale | $2.94 | -4,644 | 291.4K | -2% | -$13.7K | |
| 2026-04-27 16:28 | 2026-04-23 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | S - Sale | $5.22 | -4,697 | 296.1K | -2% | -$24.5K | |
| 2026-03-18 | 2026-03-16 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | S - Sale | $5.25 | -3,719 | 300.8K | -1% | -$19.5K | |
| 2026-01-26 | 2026-01-22 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | A - Grant | $0.00 | +250.0K | 304.5K | +459% | $0 | |
| D | 2025-03-17 | 2025-03-13 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | A - Grant | $0.00 | +52.5K | 54.5K | +2,625% | $0 |
| 2024-03-25 | 2024-03-21 | IRD | Opus Genetics, Inc. | SCHACHLE JOSEPH K | COO | P - Purchase | $2.05 | +2,000 | 2,000 | New | +$4,100 |
Purchase Sale Sale after option exercise All abbreviations